Subcommittee backs Del. Delaney’s bill to cut insulin and diabetes supply cost‑sharing to $35 HB 1214 would reduce Virginia's insulin cap from $50 to $35 per 30‑day supply and extend a $35 aggregate cap to diabetes supplies. The subcommittee reported the bill after patient advocates and clinicians testified that reduced cost shares improve adherence and outcomes.

Virginia is on the verge of making diabetes management more affordable by slashing insulin costs to just $35 per month—could this be the breakthrough patients have been waiting for?

Learn more here!

#VA #MedicationAdherence #CitizenPortal #ChronicConditionSupport #VirginiaDiabetes